About Us

Mission of the Board and Committees.

The Preventing Overdiagnosis Board is responsible for the oversight of the international Preventing Overdiagnosis scientific conferences and associated activities, including maintenance of the website: www.Preventing Overdiagnosis.net.

Someone from each of the partners in Preventing Overdiagnosis will be represented on the board, including The BMJ, Consumer Reports, Bond University’s Centre for Research in Evidence- Based Practice, the University of Oxford’s Centre for Evidence Based Medicine, and The Dartmouth Institute for Health Policy and Clinical Practice. Each board member will also have a ‘second’ who can attend meetings. While primarily an international scientific meeting, the conference encourages clinicians, policy-makers and citizen/consumer organisations to participate, as well as researchers.

The primary aim of the Board is to develop strategies to sustain the international scientific conferences. Other aims include: to encourage national or regional conferences; encourage research generation and dissemination on the problem of overdiagnosis and potential solutions; encourage the development of educational curricula; encourage development and evaluation of strategies to communicate about overdiagnosis; encourage the development of a community or network of clinicians, researchers, policy-makers and citizen/consumer advocates with an interest in the area; develop explicit guidance for constitution of the board and committees.

Functions of the Board include oversight of: the development of the scientific program for the international conference; the conference website; the conference budget; appointments to the committees, including the scientific committee and the local organising sub-committee mentioned below; approval of any contractual engagements related to the management of the conference; approval of the use of the Preventing Overdiagnosis name/logo by any national or regional meetings.

 

Preventing Overdiagnosis is a not for profit group.

Policies of the Board include: a strict policy of no industry funding or sponsorship, either direct or indirect, in any form, for all Preventing Overdiagnosis conferences and associated activities, and thus no exhibitor’s hall; an aspiration to keep the conference registration fee as low as possible, in order to encourage wide participation including from trainees/students; an aim to include consumer/citizen participants in the conference. Industry is defined as including for-profit companies/organisations which sell products including, but not limited to: healthcare services, medications, devices or insurance policies – or related organisations. More detailed policy-guidance will be developed as needed. Any surplus generated by the conference, after all costs are covered, will be used to further the explicit aims and functions expressed here.

The scientific committee has responsibility for developing the international conference scientific programme, abstract submission topics, keynote speakers, deciding on future locations/hosts, and helping develop strategies to sustain the conference and related activities. The scientific committee has a Research Day sub-committee, which will have oversight of the Research Day associated with the main international conference. The Local Organising sub- committee will have responsibility for managing all aspects of the conference planning, including venues, budgets, onsite materials, speaker liaison and website content management. This will be constituted annually, and will include at least one representative from the host institution.

 

Board

Chair – Paul Glasziou Centre for Research in Evidence-Based Practice Bond University
Fiona Godlee Editor in Chief British Medical Journal
Carl Heneghan Centre for Evidence-Based Medicine University of Oxford
Lisa Schwartz Dartmouth Institute for Health Policy and Clinical Practice
Steve Woloshin Dartmouth Institute for Health Policy and Clinical Practice

 

Scientific Committee

Co-ChairIona Heath
Co-Chair – Ray Moynihan Bond University
Co-Chair – John Brodersen University of Copenhagen
Alexandra Barratt University of Sydney
Lisa Schwartz Dartmouth Institute for Health Policy and Clinical Practice
Steve Woloshin Dartmouth Institute for Health Policy and Clinical Practice
Helen MacDonald British medical Journal
Barnett Kramer National Cancer Institute, US
Cari Almazán, Agency for Health Quality and Assessment of Catalonia (AQuAS)
Dr Yu Wang Beijing University
Guylene Theriault Quebec Medical Association
France Légaré Laval University
Carolyn Canfield -  independent citizen-patient
Priscille-Nice Sanon

Local organising Committee

Chair – Ruth Davis Centre for Evidence-Based Medicine University of Oxford
John Brodersen University of Copenhagen
Ray Moynihan Bond University
Hugo Viens Quebec Medical Association
Normand Laberge Quebec Medical Association

 

Preventing Overdiagnosis Research and Involvement – info@preventingoverdiagnosis.net
2016 Conference information – ruth.davis@phc.ox.ac.uk